The Global Liposome Drug Delivery market industry is witnessing significant growth driven by the increasing demand for targeted drug delivery systems. US, NY, UNITED STATES, February 13 ...

As a result, the liposome platform holds tremendous promise in the future of targeted cancer therapeutics to improve drug delivery while minimizing unwanted systemic bystander effects. This review ...

CNW/ -- (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and ...

Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the ...

liposome properties, such as size, surface charge and functionality, can be easily tuned. Polymeric nanocarriers can be categorized based on three drug-incorporation mechanisms. The first includes ...

Israel: Innocan Pharma Corporation has announced that it has been granted a patent in India covering a prolonged-release ...

Innovative Chronic Pain Treatment Receives IP Protection in India's $55 Billion Pharmaceutical Market HERZLIYA, Israel and CALGARY, AB, Feb. 18, 2025 /PRNewswire/ -- Innocan Pharma ...

Ahuva Cern from the Hebrew University in Jerusalem, the liposomal drug delivery platform allows for prolonged exposure and maximizes the bioavailability and therapeutic effects of cannabinoids.

I then worked within a newly established Drug Delivery Company (Lipoxen Technologies Ltd) for two years, developing their liposome drug delivery platform technology before moving into Academia to set ...